195 related articles for article (PubMed ID: 11207456)
1. Maitake extracts and their therapeutic potential.
Mayell M
Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
[TBL] [Abstract][Full Text] [Related]
2. Can maitake MD-fraction aid cancer patients?
Kodama N; Komuta K; Nanba H
Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
[TBL] [Abstract][Full Text] [Related]
3. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
Kodama N; Komuta K; Nanba H
J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of sebaceous lipogenesis by an ethanol extract of Grifola frondosa (Maitake mushroom) in hamsters in vivo and in vitro.
Nagao M; Sato T; Akimoto N; Kato Y; Takahashi M; Ito A
Exp Dermatol; 2009 Aug; 18(8):730-3. PubMed ID: 19228191
[TBL] [Abstract][Full Text] [Related]
5. Several apparent errors surfaced on reading the article in the June 2002 issue of Alternative Medicine Review by Kodama et al. entitled "Can maitake MD-fraction aid cancer patients"?
Black W
Altern Med Rev; 2002 Dec; 7(6):451; author reply 452-4. PubMed ID: 12495370
[No Abstract] [Full Text] [Related]
6. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells.
Konno S
Vet Ther; 2004; 5(4):263-71. PubMed ID: 15719326
[TBL] [Abstract][Full Text] [Related]
7. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Cross-Flow Ultrafiltration Fractions from Maitake Medicinal Mushroom, Grifoia frondosa (Agaricomycetes), Reveals Distinct Cytotoxicity in Tumor Cells.
Sari M; Hambitzer R; Lelley JI; Toepler K; Teusch N; Nickisch-Hartfiel A
Int J Med Mushrooms; 2016; 18(8):671-680. PubMed ID: 27910785
[TBL] [Abstract][Full Text] [Related]
9. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
11. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values.
Chu KK; Ho SS; Chow AH
J Clin Pharmacol; 2002 Sep; 42(9):976-84. PubMed ID: 12211223
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Ingredients and Medicinal Values of
Wu JY; Siu KC; Geng P
Foods; 2021 Jan; 10(1):. PubMed ID: 33466429
[No Abstract] [Full Text] [Related]
13. Effects of Maitake mushroom fractions on blood pressure of Zucker fatty rats.
Talpur N; Echard B; Dadgar A; Aggarwal S; Zhuang C; Bagchi D; Preuss HG
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):68-82. PubMed ID: 15080498
[TBL] [Abstract][Full Text] [Related]
14. The biological activities of the antitumor drug Grifola frondosa polysaccharide.
He Y; Zhang L; Wang H
Prog Mol Biol Transl Sci; 2019; 163():221-261. PubMed ID: 31030750
[TBL] [Abstract][Full Text] [Related]
15. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.
Roldan-Deamicis A; Alonso E; Brie B; Braico DA; Balogh GA
Cancer Med; 2016 Sep; 5(9):2427-41. PubMed ID: 27401257
[TBL] [Abstract][Full Text] [Related]
16. Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration.
Ulbricht C; Weissner W; Basch E; Giese N; Hammerness P; Rusie-Seamon E; Varghese M; Woods J
J Soc Integr Oncol; 2009; 7(2):66-72. PubMed ID: 19476741
[TBL] [Abstract][Full Text] [Related]
17. Effect of Maitake D-fraction on cancer prevention.
Nanba H; Kubo K
Ann N Y Acad Sci; 1997 Dec; 833():204-7. PubMed ID: 9616756
[No Abstract] [Full Text] [Related]
18. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7.
Sanzen I; Imanishi N; Takamatsu N; Konosu S; Mantani N; Terasawa K; Tazawa K; Odaira Y; Watanabe M; Takeyama M; Ochiai H
J Exp Clin Cancer Res; 2001 Dec; 20(4):591-7. PubMed ID: 11876556
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.
Deng G; Lin H; Seidman A; Fornier M; D'Andrea G; Wesa K; Yeung S; Cunningham-Rundles S; Vickers AJ; Cassileth B
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1215-21. PubMed ID: 19253021
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Grifola frondosa (maitake).
Adachi K; Nanba H; Kuroda H
Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):262-70. PubMed ID: 3594655
[No Abstract] [Full Text] [Related]
[Next] [New Search]